426 related articles for article (PubMed ID: 23388123)
21. Proposal of progression model for intrahepatic cholangiocarcinoma: clinicopathologic differences between hilar type and peripheral type.
Aishima S; Kuroda Y; Nishihara Y; Iguchi T; Taguchi K; Taketomi A; Maehara Y; Tsuneyoshi M
Am J Surg Pathol; 2007 Jul; 31(7):1059-67. PubMed ID: 17592273
[TBL] [Abstract][Full Text] [Related]
22. Comparative immunohistochemical expression of p63 in human cholangiocarcinoma and hepatocellular carcinoma.
Ramalho FS; Ramalho LN; Della Porta L; Zucoloto S
J Gastroenterol Hepatol; 2006 Aug; 21(8):1276-80. PubMed ID: 16872309
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma.
Zuo HQ; Yan LN; Zeng Y; Yang JY; Luo HZ; Liu JW; Zhou LX
Hepatobiliary Pancreat Dis Int; 2007 Apr; 6(2):161-5. PubMed ID: 17374575
[TBL] [Abstract][Full Text] [Related]
24. [Histological classification of hepatocellular carcinoma].
Kojiro M
Nihon Rinsho; 2001 Oct; 59 Suppl 6():203-15. PubMed ID: 11761942
[No Abstract] [Full Text] [Related]
25. Combined hepatocellular cholangiocarcinoma: prognostic factors investigated by computed tomography/magnetic resonance imaging.
Lin G; Toh CH; Wu RC; Ko SF; Ng SH; Chou WC; Tseng JH
Int J Clin Pract; 2008 Aug; 62(8):1199-205. PubMed ID: 17537192
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathological analysis of 14 patients with combined hepatocellular carcinoma and cholangiocarcinoma.
Yu XH; Xu LB; Zeng H; Zhang R; Wang J; Liu C
Hepatobiliary Pancreat Dis Int; 2011 Dec; 10(6):620-5. PubMed ID: 22146626
[TBL] [Abstract][Full Text] [Related]
27. Cholangiocarcinomas arising in cirrhosis and combined hepatocellular-cholangiocellular carcinomas share apomucin profiles.
Sasaki M; Nakanuma Y; Ho SB; Kim YS
Am J Clin Pathol; 1998 Mar; 109(3):302-8. PubMed ID: 9495202
[TBL] [Abstract][Full Text] [Related]
28. Primary liver cancer with dual expression of hepatocyte and bile duct epithelial markers.
Uenishi T; Hirohashi K; Shuto T; Tsukamoto T; Yamamoto T; Ogawa M; Kubo S; Tanaka H; Kinoshita H
Hepatogastroenterology; 2002; 49(46):1092-4. PubMed ID: 12143210
[TBL] [Abstract][Full Text] [Related]
29. Hepatocarcinoma-intestine-pancreas/pancreatic associated protein (HIP/PAP) is expressed and secreted by proliferating ductules as well as by hepatocarcinoma and cholangiocarcinoma cells.
Christa L; Simon MT; Brezault-Bonnet C; Bonte E; Carnot F; Zylberberg H; Franco D; Capron F; Roskams T; Bréchot C
Am J Pathol; 1999 Nov; 155(5):1525-33. PubMed ID: 10550309
[TBL] [Abstract][Full Text] [Related]
30. Pathology of combined hepatocellular-cholangiocarcinoma.
Yeh MM
J Gastroenterol Hepatol; 2010 Sep; 25(9):1485-92. PubMed ID: 20796144
[TBL] [Abstract][Full Text] [Related]
31. Primary intrahepatic small-cell carcinoma arising from combined hepatocellular and cholangiocarcinomas.
Khaw YL; Nolan N; Heaslip I; McCormick PA; Sheahan K
J Clin Oncol; 2011 Jul; 29(21):e630-3. PubMed ID: 21606429
[No Abstract] [Full Text] [Related]
32. Long-term prognosis of combined hepatocellular and cholangiocarcinoma after curative resection comparison with hepatocellular carcinoma and cholangiocarcinoma.
Lee JH; Chung GE; Yu SJ; Hwang SY; Kim JS; Kim HY; Yoon JH; Lee HS; Yi NJ; Suh KS; Lee KU; Jang JJ; Kim YJ
J Clin Gastroenterol; 2011 Jan; 45(1):69-75. PubMed ID: 20142755
[TBL] [Abstract][Full Text] [Related]
33. A subgroup of intrahepatic cholangiocarcinoma with an infiltrating replacement growth pattern and a resemblance to reactive proliferating bile ductules: 'bile ductular carcinoma'.
Kozaka K; Sasaki M; Fujii T; Harada K; Zen Y; Sato Y; Sawada S; Minato H; Matsui O; Nakanuma Y
Histopathology; 2007 Sep; 51(3):390-400. PubMed ID: 17553067
[TBL] [Abstract][Full Text] [Related]
34. Intrahepatic clear cell cholangiocarcinoma: immunohistochemical aspects in a very rare type of cholangiocarcinoma.
Haas S; Gütgemann I; Wolff M; Fischer HP
Am J Surg Pathol; 2007 Jun; 31(6):902-6. PubMed ID: 17527078
[TBL] [Abstract][Full Text] [Related]
35. Intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma: a Western experience.
Portolani N; Baiocchi GL; Coniglio A; Piardi T; Grazioli L; Benetti A; Ferrari Bravo A; Giulini SM
Ann Surg Oncol; 2008 Jul; 15(7):1880-90. PubMed ID: 18443881
[TBL] [Abstract][Full Text] [Related]
36. A fibrous stromal component in hepatocellular carcinoma reveals a cholangiocarcinoma-like gene expression trait and epithelial-mesenchymal transition.
Seok JY; Na DC; Woo HG; Roncalli M; Kwon SM; Yoo JE; Ahn EY; Kim GI; Choi JS; Kim YB; Park YN
Hepatology; 2012 Jun; 55(6):1776-86. PubMed ID: 22234953
[TBL] [Abstract][Full Text] [Related]
37. The diagnostic value of cytokeratins and carcinoembryonic antigen immunostaining in differentiating hepatocellular carcinomas from intrahepatic cholangiocarcinomas.
Stroescu C; Herlea V; Dragnea A; Popescu I
J Gastrointestin Liver Dis; 2006 Mar; 15(1):9-14. PubMed ID: 16680226
[TBL] [Abstract][Full Text] [Related]
38. Primary liver carcinoma in genetic hemochromatosis reveals a broad histologic spectrum.
Morcos M; Dubois S; Bralet MP; Belghiti J; Degott C; Terris B
Am J Clin Pathol; 2001 Nov; 116(5):738-43. PubMed ID: 11710692
[TBL] [Abstract][Full Text] [Related]
39. Genetic classification of combined hepatocellular-cholangiocarcinoma.
Fujii H; Zhu XG; Matsumoto T; Inagaki M; Tokusashi Y; Miyokawa N; Fukusato T; Uekusa T; Takagaki T; Kadowaki N; Shirai T
Hum Pathol; 2000 Sep; 31(9):1011-7. PubMed ID: 11014564
[TBL] [Abstract][Full Text] [Related]
40. Combined fibrolamellar carcinoma and cholangiocarcinoma exhibiting biphenotypic antigen expression: a case report.
Tanaka K; Honna T; Kitano Y; Kuroda T; Tanaka K; Morikawa N; Matsuda H; Kawashima N; Matsuoka K; Miyauchi J
J Clin Pathol; 2005 Aug; 58(8):884-7. PubMed ID: 16049296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]